

How does it work?
Transforming early cancer diagnosis
PreveCol® is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal Cancer (CRC) and advanced adenoma (AA).
Prevecol® identifies molecular biomarkers in blood, with increased sensitivity and specificity for colorectal cancer and advanced adenoma detection.
- Identifying molecular biomarkers.
- Non-invasive, just a blood test that improves colorectal cancer screening compliance
- Easy, fast, better compliance, no sedation, reliable, disruptive.
- Colorectal screening blood-based test providing competitive colorectal detection and highest accuracy for the detection of advanced adenomas (precancerous lesions).